Pamlab Report issue

For profit Phase 3 Phase 4
Founded: Covington LA United States (1986)
Status: Acquired by Nestle (2013)

Organization Overview

First Clinical Trial
2001
NCT00032435
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Pamlab, Inc. | Pamlab, L.L.C. | PAMLAB LLC | Pan American Laboratories

Active Ingredients

Marketed Drugs (1)

chlorphenesin (maolate) (1965)

Drugs in Phase 4 Trials (1)

deplin (1 trial)

Drugs in Phase 3 Trials (3)

homocysteine (1 trial)

methylfolate (4 trials)

methylphenidate (ritalin) (1 trial)

Drugs in Other Trials (1)

butenafine (mentax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 3)

Hyperkinesis (Phase 3)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 5